TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)
$16.41
+$0.05(+0.31%)
42
Overall
60
Value
10
Tech
57
Quality
Market Cap
$56.18B
Volume
2.55M
52W Range
$12.99 - $18.90
Target Price
$20.80
Company Overview
| Mkt Cap | $56.18B | Price | $16.41 |
| Volume | 2.55M | Change | +0.31% |
| P/E Ratio | 0.5 | Open | $16.51 |
| Revenue | $4.6T | Prev Close | $16.36 |
| Net Income | $107.9B | 52W Range | $12.99 - $18.90 |
| Div Yield | 0.64% | Target | $20.80 |
| Overall | 42 | Value | 60 |
| Quality | 57 | Technical | 10 |
No chart data available
Latest News
Catheter Precision Raises Capital Through New Preferred Stock
TipRanks Auto-Generated Newsdesk•5 days ago
Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside
TipRanks Clinical-Trials-Auto-Generated Newsdesk•5 days ago
Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors
TipRanks Clinical-Trials-Auto-Generated Newsdesk•5 days ago
Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors
TipRanks Clinical-Trials-Auto-Generated Newsdesk•12 days ago
Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors
TipRanks Clinical-Trials-Auto-Generated Newsdesk•12 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TAK | $16.41 | +0.3% | 2.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of) Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW